Abstract
This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.
| Translated title of the contribution | CCNU in the chemotherapy of tumours of the central nervous system (author's transl) |
|---|---|
| Original language | Italian |
| Pages (from-to) | 191-195 |
| Number of pages | 5 |
| Journal | Rivista di Patologia Nervosa e Mentale |
| Volume | 98 |
| Issue number | 3 |
| Publication status | Published - May 1977 |
ASJC Scopus subject areas
- Medicine(all)
Fingerprint Dive into the research topics of 'CCNU in the chemotherapy of tumours of the central nervous system (author's transl)'. Together they form a unique fingerprint.
Cite this
Adinolfi, D., Pavesi, L., Robustelli della Cuna, G., & Paoletti, P. (1977). L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale. Rivista di Patologia Nervosa e Mentale, 98(3), 191-195.